betrixaban and Myocardial-Infarction

betrixaban has been researched along with Myocardial-Infarction* in 3 studies

Trials

1 trial(s) available for betrixaban and Myocardial-Infarction

Article	Year
[Betrixaban reduces tromboembolic events]. Deutsche medizinische Wochenschrift (1946), 2016, Volume: 141, Issue:22 Topics: Administration, Oral; Benzamides; Causality; Comorbidity; Enoxaparin; Fibrinolytic Agents; Humans; Myocardial Infarction; Prevalence; Pyridines; Treatment Outcome; Venous Thromboembolism	2016

Other Studies

2 other study(ies) available for betrixaban and Myocardial-Infarction

Article	Year
Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients. Circulation, 2019, 02-26, Volume: 139, Issue:9 Topics: Benzamides; Enoxaparin; Female; Humans; Male; Myocardial Infarction; Pyridines; Risk Factors; Stroke	2019
The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis. Expert review of hematology, 2017, Volume: 10, Issue:8 Data from recent randomized controlled trials indicate that the incidence of stroke among acutely ill medical patients is unexpectedly high and approximates 1% at 90 days. Preliminary data suggest that betrixaban may reduce ischemic stroke in patients without atrial fibrillation. There is an unmet demand for stroke risk stratification schemes targeting hospitalized medical patients. The prognostic value of biomarkers such as natriuretic peptides and D-dimer in predicting short-term stroke remains uncertain. Future research should focus on identifying the high-risk subsets in which the benefit of anticoagulation significantly outweighs the associated hemorrhagic risk. Clinical trials: NCT00457002, NCT00571649, NCT01583218. Topics: Aged; Aged, 80 and over; Anticoagulants; Benzamides; Female; Humans; Incidence; Inpatients; Male; Middle Aged; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thrombosis	2017

Article

Year

Reduction of Cardiovascular Mortality and Ischemic Events in Acute Medically Ill Patients.

Circulation, 2019, 02-26, Volume: 139, Issue:9

Topics: Benzamides; Enoxaparin; Female; Humans; Male; Myocardial Infarction; Pyridines; Risk Factors; Stroke

2019

The risk of stroke among acutely ill hospitalized medical patients: lessons from recent trials on extended-duration thromboprophylaxis.

Expert review of hematology, 2017, Volume: 10, Issue:8

Data from recent randomized controlled trials indicate that the incidence of stroke among acutely ill medical patients is unexpectedly high and approximates 1% at 90 days. Preliminary data suggest that betrixaban may reduce ischemic stroke in patients without atrial fibrillation. There is an unmet demand for stroke risk stratification schemes targeting hospitalized medical patients. The prognostic value of biomarkers such as natriuretic peptides and D-dimer in predicting short-term stroke remains uncertain. Future research should focus on identifying the high-risk subsets in which the benefit of anticoagulation significantly outweighs the associated hemorrhagic risk. Clinical trials: NCT00457002, NCT00571649, NCT01583218.

Topics: Aged; Aged, 80 and over; Anticoagulants; Benzamides; Female; Humans; Incidence; Inpatients; Male; Middle Aged; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thrombosis

2017